Evaluating cutaneous lupus disease activity end points and their effects on quality of life as an outcome measure for clinical trials
Year: 2019
Type: article
Source: British Journal of Dermatology
DOI: 10.1111/bjd.17926
Authors: M. Tarazi, R.G. Gaffney, R. Feng, V.P. Werth
Institutions: University of Pennsylvania, Philadelphia VA Medical Center
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2925614025
